Look for:

Our offer for

LONZA GROUP AG


ISIN:
CH0013841017
WKN:
1384101

2024/04/25 13:15:36
Price
519.80 CHF
Difference -0.57% (-3.00)

General attributes

ISINCH0013841017
SymbolLONN
ExchangeSIX Swiss Exchange
CurrencyCHF
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)38,619 EUR
BenchmarkSWISS MARKET INDEX

Market data

Bid (Bid size)519.80 CHF (76)
Ask (Ask size)520.00 CHF (14)
Open522.40 CHF
High523.00 CHF
Low516.20 CHF
Close (prev. day)522.80 CHF
VWAP519.199823 CHF
Volume (pcs)33,414
Trading volume17,348,542.90
Number of trades1,342
Last size4

Futures and Options

Related Futures30
Related Options-

PDF Downloads

Company report: LONZA GROUP AGPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/04/25 13:15:36
Price
519.80 CHF
Difference -0.57% (-3.00)

General attributes

ISINCH0013841017
SymbolLONN
ExchangeSIX Swiss Exchange
CurrencyCHF
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)38,619 EUR
BenchmarkSWISS MARKET INDEX

Market data

Bid (Bid size)519.80 CHF (76)
Ask (Ask size)520.00 CHF (14)
Open522.40 CHF
High523.00 CHF
Low516.20 CHF
Close (prev. day)522.80 CHF
VWAP519.199823 CHF
Volume (pcs)33,414
Trading volume17,348,542.90
Number of trades1,342
Last size4

Performance and Risk

6m1Y3Y
Perf (%)+57.99%-9.64%-6.27%
Perf (abs.)+191.90-55.80-35.00
Beta1.331.641.42
Volatility31.2939.1133.30
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)513.80 CHF (222,108)
Ø price 30 days | Ø volume 30 days (pcs.)519.43 CHF (232,756)
Ø price 100 days | Ø volume 100 days (pcs.)432.99 CHF (242,330)
Ø price 250 days | Ø volume 250 days (pcs.)457.87 CHF (224,424)
YTD High | date559.40 CHF (2024/04/08)
YTD Low | date339.00 CHF (2024/01/08)
52 Weeks High | date599.40 CHF (2023/06/06)
52 Weeks Low | date308.60 CHF (2023/10/26)

All listings for LONZA GROUP AG

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Singapore Exchange2011/10/2109:5174.0753 SGD0.001
SIX Swiss Exchange2024/04/2513:15519.80 CHF17.351,342
London Stock Exchange2024/04/1913:14501.00 CHF1.851
Hamburg2019/06/2808:01291.30 EUR0.002
Frankfurt2019/06/2815:56293.90 EUR0.024
FINRA other OTC Issues2024/04/2420:12557.715 USD0.113
Duesseldorf2019/06/2808:11291.20 EUR0.002
Berlin2019/06/2818:45296.90 EUR0.0014

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2281&ID_TYPE_IMAGE_LOGO=2

Contact Details

LONZA GROUP AG
- -
Muenchensteinerstrasse 38 - 4002 Basel
Telefon: +41-61-316-81-11
Fax: +41-61-316-91-11
E-mail: media@lonza.com

PDF Downloads

Company report: LONZA GROUP AGPDF Download

Company Profile

Lonza Group AG is engaged in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Biologics, Small Molecules, Cell and Gene, Capsule and Health Ingredients, and Corporate. The Biologics segment serves as contract development and manufacturing partner for biopharmaceuticals, catering customers for all clinical and commercial manufacturing needs throughout the product lifecycle. The Small Molecules segment offers small molecule drug substances and intermediates related services. The Cell and Gene segment includes the Cell and Gene Technologies and Bioscience businesses. The Capsule and Health Ingredients segment provides innovative capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical companies. The Corporate segment refers to finance and accounting, legal, communication, information technology, and human resources functions. The company was founded on October 27, 1897 and is headquartered in Basel, Switzerland.

Members of Management Board

Albert M. BaehnyChairman of Managing Board
Christian SeufertMember of Executive Committee
Daniel PalmacciMember of Executive Committee
Gordon BatesMember of Executive Committee
Jean-Christophe HyvertMember of Executive Committee
Maria Soler NunezMember of Executive Committee
Philippe DeeckeMember of Executive Committee
Ulrike KaepplerMember of Executive Committee

Board of directors

Angelica KohlmannMember of the administrative board
Marion HelmesMember of the administrative board
Olivier VerscheureMember of the administrative board
Roger NitschMember of the administrative board
Barbara RichmondMember of the administrative board
Christoph MäderMember of the administrative board
Jürgen B. SteinemannMember of the administrative board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer